Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
Clinical trial NCT06588322 · RECRUITING
Trial details
- NCT number
- NCT06588322
- Sponsor
- Institut Claudius Regaud
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-08
- Primary completion
- 2029-11-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.